Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States"
Prostate Cancer
.
2019 Jul 4:2019:3425982.
doi: 10.1155/2019/3425982.
eCollection 2019.
Authors
Catherine W Saltus
1
,
Zdravko P Vassilev
2
,
Jihong Zong
2
,
Brian Calingaert
3
,
Elizabeth B Andrews
3
,
Montse Soriano-Gabarró
4
,
James A Kaye
1
Affiliations
1
RTI Health Solutions, Waltham, Massachusetts, USA.
2
Bayer US, Whippany, New Jersey, USA.
3
RTI Health Solutions, Research Triangle Park, North Carolina, USA.
4
Bayer AG, Berlin, Germany.
PMID:
31355002
PMCID:
PMC6637695
DOI:
10.1155/2019/3425982
Abstract
[This corrects the article DOI: 10.1155/2019/4387415.].
Publication types
Published Erratum